Venetoclax in relapsed/refractory blastic plasmacytoid dendritic cell neoplasm with central nervous system involvement: a  case report and review of the literature

ConclusionsVenetoclax monotherapy seems not enough to control the disease progression under CNS involvement and other treatments should be investigated.
Source: Journal of Medical Case Reports - Category: General Medicine Source Type: research